LT3193826T - Burnoje disperguojamos plėvelės kompozicija, apimanti enalaprilį, skirta hipertenzijos gydymui vaikų populiacijoje - Google Patents

Burnoje disperguojamos plėvelės kompozicija, apimanti enalaprilį, skirta hipertenzijos gydymui vaikų populiacijoje

Info

Publication number
LT3193826T
LT3193826T LTEP15732161.3T LT15732161T LT3193826T LT 3193826 T LT3193826 T LT 3193826T LT 15732161 T LT15732161 T LT 15732161T LT 3193826 T LT3193826 T LT 3193826T
Authority
LT
Lithuania
Prior art keywords
enalapril
hypertension
treatment
film composition
pediatric population
Prior art date
Application number
LTEP15732161.3T
Other languages
English (en)
Inventor
Evangelos Karavas
Efthymios Koutris
Vasiliki SAMARA
Ionna KOUTRI
Anastasia Kalaskani
Lida Kalantzi
Andreas KAKOURIS
Amalia DIAKIDOU
George GOTZAMANIS
Zaharias GEORGOUSIS
Louiza KONSTANTI
Original Assignee
Pharmathen S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen S.A. filed Critical Pharmathen S.A.
Publication of LT3193826T publication Critical patent/LT3193826T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEP15732161.3T 2014-07-31 2015-06-19 Burnoje disperguojamos plėvelės kompozicija, apimanti enalaprilį, skirta hipertenzijos gydymui vaikų populiacijoje LT3193826T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2014002095 2014-07-31
PCT/EP2015/001243 WO2016015798A1 (en) 2014-07-31 2015-06-19 Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population

Publications (1)

Publication Number Publication Date
LT3193826T true LT3193826T (lt) 2019-01-25

Family

ID=53491483

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP15732161.3T LT3193826T (lt) 2014-07-31 2015-06-19 Burnoje disperguojamos plėvelės kompozicija, apimanti enalaprilį, skirta hipertenzijos gydymui vaikų populiacijoje

Country Status (15)

Country Link
US (1) US20170165315A1 (lt)
EP (1) EP3193826B1 (lt)
CY (1) CY1121141T1 (lt)
DK (1) DK3193826T3 (lt)
ES (1) ES2705610T3 (lt)
HR (1) HRP20190083T1 (lt)
HU (1) HUE041705T2 (lt)
LT (1) LT3193826T (lt)
PL (1) PL3193826T3 (lt)
PT (1) PT3193826T (lt)
RS (1) RS58120B1 (lt)
SI (1) SI3193826T1 (lt)
SM (1) SMT201900031T1 (lt)
TR (1) TR201819662T4 (lt)
WO (1) WO2016015798A1 (lt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11007144B2 (en) 2016-11-15 2021-05-18 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201709141D0 (en) * 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
EP3773763A4 (en) * 2018-04-13 2022-03-09 Zim Laboratories Limited COMPOSITION FOR AGENTS-LOADED EDIBLE INK AND PROCESS FOR PREPARING SUITABLE SUBSTRATES FOR INGREDIENTS PRINTING ON ORODISPERSABLE FOILS
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
GR20200100430A (el) * 2020-06-01 2022-01-13 Κυριακος Ηλια Κυπραιος Ταχεως διαλυομενες στοματικες ταινιες για τη χορηγηση δια της στοματικης οδου φαρμακων και λοιπων βιοδραστικων ουσιων σε ανθρωπους
AU2023381718A1 (en) * 2022-11-14 2025-06-05 National University Of Singapore Methods of compounding an injectable drug into a film or wafer and systems thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4510083A (en) 1982-05-07 1985-04-09 Merck & Co., Inc. Process for preparing polypeptides
US4830853A (en) 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
YU48602B (sh) 1991-11-25 1998-12-23 Krka Tovarna Zdravil P.O. Postupak za dobijanje stabilne formulacije soli enalaprila
US5562921A (en) 1994-07-15 1996-10-08 Sherman; Bernard C. Stable solid pharmaceutical compositions containing enalapril maleate
US7425292B2 (en) * 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20080220029A1 (en) * 2007-03-05 2008-09-11 Charlene Ng Fast-dissolving/disintegrating film preparation having high proportion of active
EP2732813A1 (en) * 2012-11-14 2014-05-21 Hexal AG Orodispersible film compositions

Also Published As

Publication number Publication date
PL3193826T3 (pl) 2019-07-31
PT3193826T (pt) 2019-01-23
WO2016015798A9 (en) 2016-03-31
SI3193826T1 (sl) 2019-02-28
WO2016015798A1 (en) 2016-02-04
CY1121141T1 (el) 2020-05-29
HUE041705T2 (hu) 2019-05-28
RS58120B1 (sr) 2019-02-28
EP3193826A1 (en) 2017-07-26
EP3193826B1 (en) 2018-10-17
ES2705610T3 (es) 2019-03-26
US20170165315A1 (en) 2017-06-15
SMT201900031T1 (it) 2019-02-28
HRP20190083T1 (hr) 2019-03-08
DK3193826T3 (en) 2019-02-11
TR201819662T4 (tr) 2019-01-21

Similar Documents

Publication Publication Date Title
LT3197472T (lt) Rekombinantinių baltymų be fenilalanino naudojimas gydant fenilketonuriją
ZA201605822B (en) Dental implant
ZA201605724B (en) Dental implant
PL3215117T3 (pl) Listek deksametazonu do podawania doustnego
GB201404049D0 (en) Dental implant
FI20146023A7 (fi) Hammas- ja kielituki
PL3134026T3 (pl) System implantologiczny
PT3193826T (pt) Composição de película orodispersível compreendendo enalapril para o tratamento de hipertensão numa população pediátrica
EP3173024A4 (en) Dental radiography device
IL252116A0 (en) Pharmaceutical granule formulations containing dimethyl fumarate
IL242860A0 (en) A self-propelled dental device
ZA201703398B (en) Pharmaceutical composition and methods
GB201502268D0 (en) Dental composition and use
PL3232998T3 (pl) Urządzenie medyczne do wykonywania ileostomii i/albo jejunostomii
DK4000628T3 (en) Composition and method for vancomycin oral liquid
GB201406172D0 (en) Therapy and pharmaceutical composition
SMT201900592T1 (it) Composizione farmaceutica per l'uso nell'incremento del trofismo della mucosa nasale
HUE046209T2 (hu) Kompozíció porckoronggal összefüggõ fájdalom kezelésében történõ alkalmazásra
IL250235A0 (en) A peptide derived from urlc10 and a component containing it
EP3189810A4 (en) Dental implant and set thereof
EP3110453A4 (en) Tmem100 peptides and variants thereof and their use in treating or preventing diseases or conditions
PL3131572T3 (pl) Analog apc do zastosowania w zaleczaniu rany
GB201420805D0 (en) Ligatures and use thereof
IL250215A0 (en) A peptide derived from cdca1 and a component containing it
GB201513543D0 (en) Compositions for use in the treatment of diabetes